These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9771081)

  • 41. 24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.
    Pachimkul P; Yuttitham K; Thoophom P
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S81-7. PubMed ID: 21717884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma.
    Pacella E; Pacella F; Cavallotti C; Librando A; Feher J; Pecori-Giraldi J
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):477-80. PubMed ID: 20556928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.
    Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y
    Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
    Martinez-de-la-Casa JM; Castillo A; Garcia-Feijoo J; Mendez-Hernandez C; Fernandez-Vidal A; Garcia-Sanchez J
    Curr Med Res Opin; 2004 Sep; 20(9):1333-9. PubMed ID: 15383180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma.
    Tsukamoto H; Noma H; Matsuyama S; Ikeda H; Mishima HK
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):170-3. PubMed ID: 15857284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
    Konstas AG; Lake S; Maltezos AC; Holmes KT; Stewart WC
    Eye (Lond); 2001 Feb; 15(Pt 1):59-62. PubMed ID: 11318297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A topical prostaglandin for glaucoma.
    Med Lett Drugs Ther; 1996 Nov; 38(987):100-1. PubMed ID: 8914508
    [No Abstract]   [Full Text] [Related]  

  • 52. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
    Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC;
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of acute closed-angle glaucoma with miotics and timolol.
    Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA
    Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study.
    Høvding G; Aasved H
    Acta Ophthalmol (Copenh); 1987 Oct; 65(5):594-601. PubMed ID: 3321877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma.
    Airaksinen PJ
    Acta Ophthalmol (Copenh); 1979 Jun; 57(3):425-34. PubMed ID: 38623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma.
    Mastropasqua L; Costagliola C; Ciancaglini M; Carpineto P; Gallenga PE
    Acta Ophthalmol Scand Suppl; 1997; (224):24-5. PubMed ID: 9589716
    [No Abstract]   [Full Text] [Related]  

  • 57. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma.
    Moriarty AP; Dowd TC
    Arch Ophthalmol; 1993 Oct; 111(10):1313-4. PubMed ID: 8216000
    [No Abstract]   [Full Text] [Related]  

  • 58. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group.
    Puustjärvi TJ; Repo LP
    Arch Ophthalmol; 1992 Dec; 110(12):1725-9. PubMed ID: 1342582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study.
    Ohrström A; Kättström O; Polland W; Mortensen J; Stenström B
    Acta Ophthalmol (Copenh); 1984 Oct; 62(5):681-95. PubMed ID: 6391072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined timolol and epinephrine therapy for open angle glaucoma.
    Knupp JA; Shields MB; Mandell AI; Hurvitz L; Spaeth GL
    Surv Ophthalmol; 1983 Dec; 28 Suppl():280-5. PubMed ID: 6665707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.